Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients
Clinical trial NCT05009017 · UNKNOWN
Trial details
- NCT number
- NCT05009017
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-07-31
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.